RxAll Inc. announced today the signing of an MOU with CTI Africa aimed at assuring the quality of medicines delivered to millions of people in East and Southern Africa. Details of the MOU are not yet public.
RxAll Inc is an AI platform that provides proprietary AI nanoscanners and a mobile app to regulators and pharmacies for quality assurance and pharmacovigilance surveillance of prescription medicines and narcotics.
CTI Africa and its subsidiary M_PWR DATA, are data-driven social enterprises focused on providing rural communities in sub-Saharan Africa with holistic solutions to their economic and social challenges. The organization’s mission is to help bring all Africans into the twenty-first century by leveraging the latest technologies and best practices in healthcare, agriculture, renewable energy, electronic banking, data, and clean water.
“We are excited about what this partnership means for RxAll. CTI Africa is an incredible partner with extensive operational experience, especially in East and Southern Africa,” says RxAll CEO Adebayo Alonge. “We are looking forward to an impactful journey in this region as we leverage this partnership to work with country regulators in the region to improve the quality of medicines delivered to patients.”
CTI Africa’s senior team has almost a century of experience in Africa, in senior positions in national government and international agencies. Their combined skill set enables CTI Africa to create unique programs. “CTI is very keen to demonstrate the power of our unique ‘SmartHome-SmartVillage Ecosystem’ as we roll our pilot in Uganda. RxAll’s AI and diagnostic solutions will be part of the technology revolution that will change the lives of millions in the developing world”, says Michael Landau, CTI Africa’s Chairman.
CTI Africa is a company engaged with the World Bank, the United Nations, and many of host country governments in Africa.
“CTI Africa’s mission is to enable access to high tech solutions such as RxAll for bottom of the pyramid populations living in remote areas in East and Southern Africa,” Mr. Adebayo says. “Their advisors include Nelson Mandela’s grandsons. A joint venture with a company with such an extensive local network enables us reach a population segment that is disproportionately affected by the fake drugs epidemic sweeping Africa.”
“With the RxAll platform and CTI Africa’s local operational know-how, we can now hold those who peddle poor quality medicines in East and Southern Africa accountable and save thousands of lives,” remarks Mr. Adebayo.
For more information on RxAll, check out: https://www.rxall.net/
More information on CTI Africa is at: http://www.ctiafrica.com/
